Tumor necrosis factor-α promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo bay cohort project IX

Genetic Epidemiology

Volumn 21, Issue 3, 2001, Pages 201-211

  Aidoo, Michael ^a   McElroy, Peter D ^a   Kolczak, Margarette S ^a   Terlouw, Dianne J ^b,c   ter Kuile, Feiko O ^a,b,c   Nahlen, Bernard ^a,b   Lal, Altaf A ^a   Udhayakumar, Venkatachalam ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Malaria; Polymorphism; Premature birth

Indexed keywords

ADENINE; GUANINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA 2; UNCLASSIFIED DRUG;

ALLELE; ANEMIA; ARTICLE; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFANT; INFANT MORTALITY; KENYA; MAJOR CLINICAL STUDY; MALARIA; MORBIDITY; NEWBORN; NUCLEIC ACID BASE SUBSTITUTION; PARASITEMIA; PLASMODIUM FALCIPARUM; PREMATURE LABOR; PROMOTER REGION; REGRESSION ANALYSIS; RISK FACTOR;

ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE; KENYA; MALARIA, FALCIPARUM; MALE; OBSTETRIC LABOR, PREMATURE; POISSON DISTRIBUTION; POLYMORPHISM, GENETIC; PREGNANCY; PROMOTER REGIONS (GENETICS); PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034763963     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/gepi.1029     Document Type: Article

References (34)

1. Tumor necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice
2. TNF IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor
3. Tumor necrosis factor in the pathogenesis of infectious diseases
4. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission. I. Description of study site, general methodology and study population
5. Polymorphism in the tumor necrosis factor genes associated with mucocutaneous leishmaniasis
6. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-a) gene promoter and with elevated TNF-a levels in tear fluid
7. A promoter mutation that increases transcription of the tumor necrosis factor-a gene is not associated with pre-term delivery
8. Serum tumor necrosis factor in newborns at risk for infections
9. Apolymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria
10. TNF concentration in fatal, no-fatal cerebral, and uncomplicated Plasmodium falciparum malaria
11. Tumor necrosis factor gene polymorphism influences TNF-alpha production in lipopolysaccharide stimulated whole blood cell culture in healthy humans
12. Variation in the TNF-a promoter region is associated with susceptibility to cerebral malaria
13. Severe malaria anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles
14. Association of TNF2, a TNF-a promoter polymorphism, with septic shock susceptibility and mortality
15. Variation in the tumor necrosis factor-a gene promoter region may be associated with death from meningococcal disease
16. Tumor necrosis factor-a promotes sustained cyclooxygenase-2 expression: Attenuation by dexamethasone and NSAIDs
17. Proinflammatory and anti-inflammatory cytokines in meningococcal disease
18. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of pre-term premature rupture of fetal membranes
19. A fetal systemic inflammatory response is followed by the spontaneous onset of pre-term parturition
20. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy
21. Enhanced expression of cytokines may play a fundamental role in the mechanism of immunologically mediated recurrent spontaneous abortion
22. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa
23. Tumor necrosis factor-a stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells
24. Inflammatory mechanisms in neonatal chronic lung disease
25. Malaria infection and morbidity in infants in relation to genetic polymorphisms in Tanzania
26. Coordinate expression of inducible nitric oxide synthase and cyclooxygenase-2 genes in uterine tissues of endotoxin-treated pregnant mice
27. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome
28. TNFa*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans
29. Elevated second-trimester amniotic fluid interleukin-6 levels predict pre-term delivery
30. Release of tumor necrosis factor: An innate host characteristic that may contribute to the outcome of meningococcal disease
31. Single base polymorphism in the human tumor necrosis factor alpha (TNFa) gene detectable by NcoI restriction of PCR product
32. An allelic polymorphism within the human tumor necrosis factor promoter region is strongly associated with HLAA1, B8, and DR3 alleles
33. Genetics of tumor necrosis factor-a in autoimmune, infectious and neoplastic diseases
34. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation